Lack of antimicrobial bactericidal activity in Mycobacterium abscessus. (scientific article)

Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description [...]

Q28297239

Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis

Q29615255

Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients

Q33385700

Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus

Q33471490

Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing

Q34528945

Mab_3168c, a putative acetyltransferase, enhances adherence, intracellular survival and antimicrobial resistance of Mycobacterium abscessus

Q34807688

Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme

Q35127937

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

Q35474824

Pharmacodynamics of antimicrobial drugs

Q35861670

Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria

Q36156072

Mutants of Escherichia coli permeable to actinomycin

Q36453101

Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria

Q36702951

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

Q36727850

A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae

Q37144788

Mycobacterium abscessus: a new antibiotic nightmare

Q37980031

Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.

Q39782444

rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria

Q40404155

Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study

Q41082564

Escherichia coli physiology in Luria-Bertani broth

Q41880538

Construction of Mycobacterium abscessus defined glycopeptidolipid mutants: comparison of genetic tools

Q42111834

Qualitative and quantitative drug-susceptibility tests in mycobacteriology

Q42210562

Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns

Q43034525

Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus

Q43637410

Transmission of M abscessus in patients with cystic fibrosis

Q43788456

A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae

Q45224934

Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).

Q45354298

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

Q46862305

Differentiation of Mycobacterium species by direct sequencing of amplified DNA.

Q48255458

Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease.

Q51508965

Aminoglycoside 2'-N-acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2')-Ic gene from Mycobacterium tuberculosis and the aac(2')-Id gene from Mycobacterium smegmatis.

Q52525612

Interpretive reading of in vitro antibiotic susceptibility tests (the antibiogramme)

Q77696046

Laboratory Maintenance of Mycobacterium abscessus

Q84974848

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

Mycobacterium abscessus

Q6946978

P304

page(s)

3828-3836

P577

publication date

2014-04-21

P1433

published in

Antimicrobial Agents and Chemotherapy

Q578004

P1476

title

Lack of antimicrobial bactericidal activity in Mycobacterium abscessus

P478

volume

Reverse relations

cites work (P2860)

Q59132952	: Shapeshifter of the Mycobacterial World
Q36001167	A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus.
Q41532035	Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria.
Q40772367	Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
Q40093529	Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish
Q50271090	Biological evaluation of diphenyleneiodonium chloride (DPIC) as a potential drug candidate for treatment of non-tuberculous mycobacterial infections
Q99712408	Compromised longevity due to Mycobacterium abscessus pulmonary disease in lungs scarred by tuberculosis
Q26749480	Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives
Q40281966	Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Q90479544	Extreme Drug Tolerance of Mycobacterium abscessus "Persisters"
Q35925603	Genome-wide mosaicism within Mycobacterium abscessus: evolutionary and epidemiological implications
Q35746225	In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model
Q38969052	Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment
Q36575916	Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives
Q64996348	MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections.
Q57461259	Mutations in the MAB_2299c TetR regulator confer cross-resistance to clofazimine and bedaquiline in
Q57832878	Mutations in the MAB_2299c TetR regulator confer cross-resistance to clofazimine and bedaquiline in Mycobacterium abscessus
Q61806023	Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles
Q49622474	Mycobacterium abscessus Complex Infections: A Retrospective Cohort Study
Q37581285	Mycobacterium abscessus D-alanyl-D-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity.
Q50134131	Mycobacterium abscessus Smooth And Rough Morpohotypes Form Antimicrobial-Tolerant Biofilm Phenotypes But Are Killed by Acetic Acid
Q26822822	Mycobacterium abscessus subsp abscessus lung disease: 'trouble ahead, trouble behind…'
Q52596288	NTM drug discovery: status, gaps and the way forward.
Q55260423	Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms.
Q47756838	Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.
Q41162984	Pyrosequencing analysis of bacterial diversity in dental unit waterlines.
Q47321117	Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus
Q36251994	Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384.
Q40071545	Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
Q36158384	Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models
Q92170032	Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice
Q39108163	Time-kill kinetics of antibiotics active against rapidly growing mycobacteria
Q26775974	US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
Q40483942	Unclear liver lesions in a 19-year-old woman with acute myeloid leukemia